Magnetar Financial Acquires Stake in ADMA Biologics

Institutional investor buys over 100,000 shares of biotech company

Mar. 13, 2026 at 10:05am

Got story updates? Submit your updates here. ›

Magnetar Financial LLC, an institutional investor, acquired a new stake of 108,085 shares in ADMA Biologics Inc (NASDAQ:ADMA), a biotechnology company, during the third quarter. The stake is valued at approximately $1.585 million.

Why it matters

This investment by Magnetar Financial, a prominent institutional investor, signals confidence in ADMA Biologics' growth potential. ADMA Biologics focuses on developing and commercializing specialty plasma-derived biologics for the treatment of immunodeficiencies and infectious diseases.

The details

According to a 13F filing with the Securities and Exchange Commission (SEC), Magnetar Financial acquired the new stake in ADMA Biologics during the third quarter. The investment represents a strategic move by the institutional investor to gain exposure to the biotech company's operations and product pipeline.

  • Magnetar Financial acquired the new stake in ADMA Biologics during the third quarter.

The players

Magnetar Financial LLC

An institutional investor that acquired a new stake in ADMA Biologics Inc.

ADMA Biologics Inc

A biotechnology company that focuses on developing and commercializing specialty plasma-derived biologics for the treatment of immunodeficiencies and infectious diseases.

Got photos? Submit your photos here. ›

The takeaway

This investment by Magnetar Financial underscores the institutional investor's confidence in ADMA Biologics' growth potential within the biotech industry. The acquisition of the new stake signals that Magnetar sees value in ADMA's product pipeline and business strategy.